01How much did potassium rise in hypertension on enalapril alone?
About 0.2 mEq/L on average when Vasotec was used alone for up to 48 weeks. When a thiazide sat with it, there was essentially no change in serum potassium. The small aldosterone drop is the labelled reason potassium can creep up. Inhibition of ACE lowers angiotensin II, which lowers that aldosterone push.
That mean is not a personal ceiling. The dose page does not treat 10 mg as potassium-proof. The cough page is a throat problem, not a potassium problem. A person who feels fine can still have a high lab.
02Did heart-failure trials see a higher rate?
Hyperkalemia showed in 3.8 percent of heart-failure patients in those trials and was not listed as a discontinuation cause there. That is a higher rate than the hypertension one-percent line. Heart-failure charts also carry diuretics and kidney strain more often.
The heart-failure start is still 2.5 mg under watch. Potassium is one of the labs that watch is for, along with pressure and creatinine. Hyponatremia under 130 mEq/L or creatinine over 1.6 mg/dL already slows that titration. A high potassium on that same chart is another reason the steps wait.
03Can creatinine rise on the same tablet?
Yes. In hypertension with renal-artery stenosis, BUN and creatinine rose in 20 percent; those rises were almost always reversible when enalapril, the diuretic, or both stopped. Watch kidney function in the first weeks there.
On Vasotec alone in essential hypertension, minor reversible BUN or creatinine rises sat at about 0.2 percent. With heart failure plus a diuretic, those rises sat at about 11 percent and led to discontinuation in 1.2 percent. Some people with no obvious renal-artery disease still see a small, short rise, more often if a diuretic is already there.
04What about salt substitutes and potassium pills?
The dosage and precaution lines name three stacks: potassium supplements, potassium salt substitutes, and potassium-sparing diuretics. Any of those with enalapril can lift serum potassium. 'Lite salt' is not a free lunch on this tablet. A multivitamin that hides a potassium salt counts as a supplement if potassium is on the panel.
People reach for a salt substitute because the clinician asked them to cut sodium. That swap can undo the potassium picture. Ask before the shaker changes. Dual blockade with another renin-angiotensin drug plus aliskiren raises the same hyperkalemia and kidney risks.
05How often did potassium cross 5.7 mEq/L?
About one percent of hypertensive patients in clinical trials. Most of those were isolated values that resolved even if the tablet continued. Hyperkalemia led to discontinuation in 0.28 percent of hypertensive patients. The cutoff they used was greater than 5.7 mEq/L.
A single high lab does not automatically end the tablet. A repeating high lab, weakness, a slow pulse, or a salt-substitute habit belongs back in the clinic the same week. Heart-failure work saw hyperkalemia in 3.8 percent, a higher rate on a sicker chart.
06What if a NSAID is already on the chart?
In older people, volume-depleted people, or people with reduced kidney function, an NSAID - including a COX-2 tablet - with enalapril can worsen kidney function, sometimes to acute renal failure. Those changes are usually reversible. Periodic kidney labs belong on that pair. Lithium toxicity has been reported when lithium sits with an ACE inhibitor; a few Vasotec cases reversed when both stopped.
Some reports say NSAIDs can blunt the pressure effect of an ACE inhibitor. A one-off pharmacology look with indomethacin or sulindac did not show that blunting on Vasotec, but the broader ACE-inhibitor reports still sit on the label. Aliskiren stays off the chart in diabetes and is avoided when GFR is under 60 mL/min.